Use App
Trending
News
Earnings
All
DIA
0.48%
SPY
0.10%
QQQ
1.12%
Trending
SONY
1.40%
TAO
0.50%
SHAK
1.98%
LEGN
5.57%
BB.TSX
0.91%
UBER
4.31%
ROKU
0.21%
LQDA
3.16%
VST
3.31%
EQT
0.67%
SONY
1.40%
TAO
0.50%
SHAK
1.98%
LEGN
5.57%
BB.TSX
0.91%
UBER
4.31%
ROKU
0.21%
LQDA
3.16%
VST
3.31%
EQT
0.67%
Feed
News
Sentiment
Earnings
Fundamentals
Info
home
Symbol
MLTX
Exchange:
NASDAQ
·
Updated 07:48 PM EDT
MLTX
MoonLake Immunotherapeutics
$19.02
$0.34
(1.76%)
Today
·
Closed $19.02
$0.0744
(0.39%)
After Hours
6
,
4
0
7
6
,
4
0
7
Earnings
Aug 4
Mkt Cap
$1.6B
Vol
650,857.00
Full Chart
Fundamentals
Mkt Cap
$1.6B
Volume
-
52W High
$62.75
52W Low
$5.95
PE Ratio
-4.91
Avg. Volume
1.31M
EPS (Annual)
-$3.53
P/B
5.40
Rev/Employee
$0.00
Earnings
Aug 04
Advertisement
|
Remove ads.
Latest MLTX News
View
SLS Vs MLTX: Retail Traders Race To Pick Merck’s Next Biotech Buyout As Keytruda’s $31.7B Patent Cliff Nears
Stocktwits
MoonLake Immunotherapeutics' CFO Sells 39K Shares
Nasdaq News: Markets
MoonLake Immunotherapeutics (MLTX) Outlook Strengthens as Analysts See Major Opportunity in Hidradenitis Suppurativa
Yahoo! Finance: News
Loading...
Top Discussions
HIMS
$HIMS stock is tumbling today, reversing yesterday's rally, even after an FDA panel recommended adding several peptides to the compounding list. Are you buying the dip?
5
6
1K votes
SPY
What do you think the S&P 500's ($SPY) return will be next week?
35
71
10.4K votes
HIMS
The FDA is deciding whether to add peptides to the compounding list, a ruling that could be huge for $HIMS. How do you think it goes?
5
2
524 votes
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile